Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,280.00
-250.00 (-3.32%)
At close: Apr 8, 2026

Bukwang Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
718,279373,446314,207417,573598,978883,065
Market Cap Growth
129.35%18.85%-24.75%-30.29%-32.17%-54.11%
Enterprise Value
582,744236,540280,401368,683519,044826,852
Last Close Price
7280.003785.004109.785461.807834.5511550.36
PE Ratio
47.8929.74----
Forward PE
-58.7558.7558.7558.7558.75
PS Ratio
3.581.861.963.323.144.84
PB Ratio
2.111.101.291.782.203.15
P/TBV Ratio
2.141.111.321.932.343.36
P/FCF Ratio
50.5626.299.69-49.2534.31
P/OCF Ratio
33.4617.409.14-36.3933.29
EV/Sales Ratio
2.901.181.752.932.724.53
EV/EBITDA Ratio
29.6212.0448.99-106.2379.01
EV/EBIT Ratio
41.0916.70173.34--147.08
EV/FCF Ratio
41.0216.658.65-42.6732.12
Debt / Equity Ratio
0.240.240.330.340.000.01
Debt / EBITDA Ratio
4.094.0913.88-0.190.15
Debt / FCF Ratio
5.665.662.45-0.080.06
Net Debt / Equity Ratio
-0.40-0.40-0.21-0.31-0.31-0.29
Net Debt / EBITDA Ratio
-6.91-6.91-8.852.16-17.31-7.90
Net Debt / FCF Ratio
-9.56-9.56-1.565.89-6.95-3.21
Asset Turnover
0.470.470.400.300.480.46
Inventory Turnover
2.332.331.751.662.872.36
Quick Ratio
2.092.094.371.933.904.79
Current Ratio
2.572.575.762.614.905.95
Return on Equity (ROE)
4.25%4.25%-1.45%-13.60%-1.54%-1.01%
Return on Assets (ROA)
2.08%2.08%0.25%-5.65%-0.04%0.88%
Return on Invested Capital (ROIC)
6.93%7.11%0.91%-21.45%-0.12%-2.07%
Return on Capital Employed (ROCE)
4.00%4.00%0.50%-11.30%-0.10%1.60%
Earnings Yield
1.75%3.36%-0.84%-7.50%-0.41%-0.10%
FCF Yield
1.98%3.80%10.32%-2.92%2.03%2.92%
Payout Ratio
39.28%39.28%----
Buyback Yield / Dilution
-21.98%-21.98%1.06%-0.01%0.25%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.